Verastem CEO sells small share block for RSU withholding
Verastem, Inc. reported that its President and CEO, who also serves as a director, carried out a small sale of company stock.
Rhea-AI Filing Summary
Verastem, Inc. reported that its President and CEO, who also serves as a director, carried out a small sale of company stock. On 12/16/2025, the executive sold 393 shares of Verastem common stock at a price of $9.14 per share. According to the filing, this sale was made to satisfy statutory withholding requirements related to the vesting of restricted stock units, meaning it was tied to equity compensation rather than an open-market portfolio decision. After this transaction, the executive still beneficially owns 410,425 shares of Verastem common stock, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 393 | $9.14 | $4K |
Footnotes (1)
- F1. The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Verastem (VSTM) disclose in this Form 4?
Verastem disclosed that its President and CEO, who is also a director, sold 393 shares of common stock on 12/16/2025 at $9.14 per share.
Is this Verastem (VSTM) Form 4 filed by more than one reporting person?
No. The document indicates that the Form is filed by one reporting person, not by a group.
What is the Verastem (VSTM) executive’s role mentioned in this filing?
The reporting person is identified as both a Director and an Officer, serving as President and CEO of Verastem, Inc.
AI-generated analysis. How Rhea-AI works. Not financial advice.